Two Sigma Securities’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-9,261
Closed -$523K 3081
2024
Q2
$391K Sell
9,261
-9,186
-50% -$505K ﹤0.01% 1752
2024
Q1
$1.27M Buy
18,447
+9,445
+105% +$597K 0.01% 995
2023
Q4
$666K Buy
+9,002
New +$590K 0.01% 1335
2023
Q3
Sell
-4,559
Closed -$387K 3075
2023
Q2
$428K Buy
+4,559
New +$356K 0.01% 1552
2023
Q1
Sell
-5,820
Closed -$374K 2829
2022
Q4
$288K Buy
+5,820
New +$238K 0.01% 1573
2022
Q3
Sell
-9,578
Closed -$377K 2742
2022
Q2
$377K Buy
9,578
+2,254
+31% +$121K 0.01% 1115
2022
Q1
$512K Buy
+7,324
New +$535K 0.02% 1005
2018
Q3
Sell
-4,701
Closed -$307K 2699
2018
Q2
$281K Buy
+4,701
New +$253K ﹤0.01% 2103
2017
Q3
Sell
-8,385
Closed -$297K 999
2017
Q2
$297K Buy
+8,385
New +$259K 0.06% 367

Other funds holding EXAS

Two Sigma Securities's EXAS Position: Q3 2024 in Review

Two Sigma Securities sold out of Exact Sciences (EXAS) in Q3 2024, closing a stake of 9,261 shares — an estimated $523K sold.

Two Sigma Securities first reported a position in EXAS in Q2 2017 and held it in 9 quarters. The position peaked at $1.27M in Q1 2024. 599 funds tracked by Wall St. Rank hold EXAS as of Q3 2024.

  • Two Sigma Securities reported no remaining Exact Sciences position as of Q3 2024 after selling out during the quarter.
  • Two Sigma Securities sold 9,261 Exact Sciences shares in Q3 2024, an estimated $523K.
  • Two Sigma Securities first reported a position in Exact Sciences in Q2 2017 and held it in 9 quarters.
  • Two Sigma Securities's Exact Sciences position peaked at $1.27M in Q1 2024.
  • 599 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2024.

Based on Two Sigma Securities's 13F filing for Q3 2024, filed 14 Nov 2024.